Compare ENTG & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTG | PEN |
|---|---|---|
| Founded | 1966 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 10.9B |
| IPO Year | 2000 | 2015 |
| Metric | ENTG | PEN |
|---|---|---|
| Price | $89.12 | $299.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 16 |
| Target Price | $98.25 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 2.8M | 479.9K |
| Earning Date | 10-30-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.45% | N/A |
| EPS Growth | 26.59 | ★ 367.34 |
| EPS | 1.90 | ★ 4.14 |
| Revenue | ★ $3,222,508,000.00 | $1,333,798,000.00 |
| Revenue This Year | $0.27 | $16.77 |
| Revenue Next Year | $6.22 | $14.12 |
| P/E Ratio | ★ $46.93 | $72.65 |
| Revenue Growth | 0.59 | ★ 14.61 |
| 52 Week Low | $60.75 | $221.26 |
| 52 Week High | $112.36 | $310.00 |
| Indicator | ENTG | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 67.77 |
| Support Level | $72.23 | $284.95 |
| Resistance Level | $75.13 | $298.69 |
| Average True Range (ATR) | 3.62 | 8.02 |
| MACD | 2.05 | 0.11 |
| Stochastic Oscillator | 95.30 | 91.50 |
Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.